http://www.congoo.com/feed/newschannelsfeed.aspx?chid=22&catid=156News Feed for - Pharmaceutical-Industryhttp://www.congoo.com/news/addstorycomment.aspx?st=96229718&Channel_ID=22&Category_ID=1562009-11-23T15:37:00ATLANTA, Nov. 23 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, announced today that it is scheduled to participate Reutershttp://www.congoo.com/news/addstorycomment.aspx?st=96307498&Channel_ID=22&Category_ID=1562009-11-23T15:48:00TOP MARKET NEWS (RTTNews) - Printer and copier company Xerox Corp. (XRX: News ) said Monday it has resolved a lawsuit brought on by shareholders of takeover target Affiliated Computer Services Inc. (ACS: RTTNews.comhttp://www.congoo.com/news/addstorycomment.aspx?st=96300344&Channel_ID=22&Category_ID=1562009-11-23T12:30:00Goal of Trial Achieved Demonstrating Potentially Less Frequent Administration Using Lower Daily Dose NOVATO, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Raptor Pharmaceutical Corp. ('Raptor' or the 'Company') Reutershttp://www.congoo.com/news/addstorycomment.aspx?st=96303607&Channel_ID=22&Category_ID=1562009-11-23T13:36:00Companies: AXA (AXA), Camden Property Trust (CPT), Domtar, Inc. (DTC), Ferro Corp. (FOE), Pfizer, Inc. (PFE), Ryland Group, Inc. (The) (RYL), U.S. Foodservice (UFS) Despite weak dollar, US stocks traded Zibbhttp://www.congoo.com/news/addstorycomment.aspx?st=96307599&Channel_ID=22&Category_ID=1562009-11-23T13:50:00SAN DIEGO--(Business Wire)-- Nereus Pharmaceuticals, Inc., a pioneer in drug discovery from marine microbial sources, today announced positive interim results from a randomized Phase 2 clinical trial Reutershttp://www.congoo.com/news/addstorycomment.aspx?st=96325615&Channel_ID=22&Category_ID=1562009-11-23T16:36:00Stocks on the move Real-time Equity news U.S. stock market report 1047 ET 23Nov-King Pharma calls popular again ------------------------------------------------------------------------------ King Pharmaceuticals Forbes.comhttp://www.congoo.com/news/addstorycomment.aspx?st=96305287&Channel_ID=22&Category_ID=1562009-11-23T12:52:00CAMBRIDGE, Mass. (Business Wire) -- ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that the Company and collaborating investigators from five major oncology research centers in the United Globe Investorhttp://www.congoo.com/news/addstorycomment.aspx?st=96308959&Channel_ID=22&Category_ID=1562009-11-23T13:33:00CARLSBAD, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Dear Isis Supporters and Shareholders, I would like to start by thanking you for your continuing support of Isis. We believe we are at one of the most Reutershttp://www.congoo.com/news/addstorycomment.aspx?st=96299775&Channel_ID=22&Category_ID=1562009-11-23T12:15:00PRINCETON, N.J. The DMC reviewed any potential drug discontinuations, incidence and details of adverse events, and selected laboratory assessments. No safety events in the DMC review were considered significantly Forbes.comhttp://www.congoo.com/news/addstorycomment.aspx?st=96301928&Channel_ID=22&Category_ID=1562009-11-23T13:08:007:00am EST showComments allowSLCall replaceString(oldS, newS, fullS) return Share [] [] * Spectrum Completes Asia Partnerships For Apaziquone * Total Deal Value For South Korea Could Exceed $19 Million Reutershttp://www.congoo.com/news/addstorycomment.aspx?st=96314928&Channel_ID=22&Category_ID=1562009-11-23T15:06:00* Had sought refund for money spent on withdrawn drug * Suit had been filed in 2005 NEW YORK, Nov 23 (Reuters) - A Texas court has dismissed a lawsuit brought by the state against drugmaker Merck & Reutershttp://www.congoo.com/news/addstorycomment.aspx?st=96313271&Channel_ID=22&Category_ID=1562009-11-23T15:17:00Companies: Immunovaccine Inc (IMMVF), Immunovaccine Inc (IMV) Immunovaccine Inc. (TSX VENTURE: IMV), a vaccine development company, today announced the signing of an exclusive, worldwide license agreement Zibbhttp://www.congoo.com/news/addstorycomment.aspx?st=96308891&Channel_ID=22&Category_ID=1562009-11-23T13:33:00ALISO VIEJO, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Oceanside Pharmaceuticals, part of Valeant Pharmaceuticals International (NYSE: VRX), today announced that it has now launched chlordiazepoxide hydrochloride Reutershttp://www.congoo.com/news/addstorycomment.aspx?st=96302960&Channel_ID=22&Category_ID=1562009-11-23T12:44:00WORCESTER, Mass. (Business Wire) -- RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA Globe Investorhttp://www.congoo.com/news/addstorycomment.aspx?st=96316552&Channel_ID=22&Category_ID=1562009-11-23T15:17:00Companies: Montreal Exchange Inc (BSEMF), Orbus Pharma Inc (OBSPF), Orbus Pharma Inc (ORB), TMX Group Inc (TSXGL) DELISTING REVIEW - Orbus Pharma Inc. (the "Company") - Further to TSX Bulletin No. 2009-1190 Zibbhttp://www.congoo.com/news/addstorycomment.aspx?st=96316134&Channel_ID=22&Category_ID=1562009-11-23T15:11:00* Says needs to update data, unrelated to safety or efficacy * Glaxo had filed for prostate cancer risk reduction Oct. 1 (Adds explanation for withdrawal, background) LONDON, Nov 23 (Reuters) - GlaxoSmithKline Reuters UKhttp://www.congoo.com/news/addstorycomment.aspx?st=96323695&Channel_ID=22&Category_ID=1562009-11-23T16:23:00TOP MARKET NEWS (RTTNews) - Specialty pharmaceutical company Cumberland Pharmaceuticals Inc. (CPIX: News ), Monday said its ibuprofen injection Caldolor showed positive results, significantly reduced RTTNews.comhttp://www.congoo.com/news/addstorycomment.aspx?st=96318543&Channel_ID=22&Category_ID=1562009-11-23T15:40:00RESEARCH TRIANGLE PARK, NC, Nov 23 (MARKET WIRE) -- Proposed legislation would require every pharmaceutical, biotech and medical device company to report all payments they make to physicians. Included Reutershttp://www.congoo.com/news/addstorycomment.aspx?st=96313018&Channel_ID=22&Category_ID=1562009-11-23T14:50:00(RTTNews) - Cumberland Pharmaceuticals Inc. (CPIX: News ) announced positive new top-line results from a study evaluating the safety and efficacy of Caldolor Injection in treating fever in hospitalized RTTNews.comhttp://www.congoo.com/news/addstorycomment.aspx?st=96302813&Channel_ID=22&Category_ID=1562009-11-23T13:34:00Raptor Pharma Announces Positive Data On Reveals Results From Phase 2b Trial Of DR Cysteamine- Raptor Pharma Announces Positive Interim Phase 2a Clinical Data In Non-Alcoholic Steatohepatitis - Raptor RTTNews.comhttp://www.congoo.com/news/addstorycomment.aspx?st=96298495&Channel_ID=22&Category_ID=1562009-11-23T11:24:00REDWOOD CITY, Calif.--(Business Wire)-- A.P. Pharma, Inc. (Nasdaq:APPA), a specialty pharmaceutical company, today announced that, on November 19, 2009, the Company received notice from the Nasdaq Listing Reutershttp://www.congoo.com/news/addstorycomment.aspx?st=96255745&Channel_ID=22&Category_ID=1562009-11-23T15:46:00Pfizer has announced that the FDA has approved Geodon (ziprasidone HCI) Capsules for maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate in adults. The approval is based PharmaceuticalProcessinghttp://www.congoo.com/news/addstorycomment.aspx?st=96307596&Channel_ID=22&Category_ID=1562009-11-23T13:08:00WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck said today that Travis County, Texas District Court Judge Scott H. Jenkins granted Merck's motion for summary judgment, dismissing all claims in a VIOXX-related Business Wirehttp://www.congoo.com/news/addstorycomment.aspx?st=96307189&Channel_ID=22&Category_ID=1562009-11-23T13:08:00Newly released report, MethylGene Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile, provides detailed company analysis Published on November 23, 2009by Press Office(Companiesandmarkets.com OfficialSpinhttp://www.congoo.com/news/addstorycomment.aspx?st=96304432&Channel_ID=22&Category_ID=1562009-11-23T12:40:00SAN DIEGO, Nov. 23 /PRNewswire/ -- Victory Pharma, Inc. ('Victory') announced today the launch of NAPRELAN Dose Card, a further extension of Victory's NAPRELAN franchise. NAPRELAN Dose Card is designed Houston Chronicle